Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-16 4:30 pm Sale | 13G | AVROBIO Inc. AVRO | CITADEL ADVISORS LLC | 1,668,811 4% | -20,211 (-1.20%) | View |
| 2021-02-16 4:30 pm Purchase | 13G | SURO CAP CORP NT SSSSL | CITADEL ADVISORS LLC | 1,276,990 6.1% | 169,174 (+15.27%) | View |
| 2021-02-16 4:30 pm Purchase | 13G | Concord Acquisition Corp CND | CITADEL ADVISORS LLC | 1,800,094 6.3% | 16 (+0.00%) | View |
| 2021-02-16 4:30 pm Purchase | 13G | ZeroFox Holdings Inc. ZFOX | CITADEL ADVISORS LLC | 870,009 5% | 3,072 (+0.35%) | View |
| 2021-02-16 4:30 pm Purchase | 13G | COEPTIS THERAPEUTICS HLDGS INC COEP | CITADEL ADVISORS LLC | 623,209 6.5% | 623,209 (New Position) | View |
| 2021-02-16 4:30 pm Sale | 13G | SUTRO BIOPHARMA INC. STRO | CITADEL ADVISORS LLC | 1,301,804 2.9% | -427,172 (-24.71%) | View |
| 2021-02-16 4:30 pm Purchase | 13G | NUSCALE POWER Corp SMR | CITADEL ADVISORS LLC | 1,346,600 5.9% | 1,346,600 (New Position) | View |
| 2021-02-16 4:30 pm Sale | 13G | Zentalis Pharmaceuticals Inc. ZNTL | CITADEL ADVISORS LLC | 1,503,870 3.7% | -626,094 (-29.39%) | View |
| 2021-02-16 4:30 pm Purchase | 13G | EDTECHX HLDGS ACQUISITION CORP EDTX | CITADEL ADVISORS LLC | 550,558 4.8% | 460 (+0.08%) | View |
| 2021-02-16 4:30 pm Purchase | 13G | Periphas Capital Partnering Corp PCPC | CITADEL ADVISORS LLC | 800,752 4.8% | 800,752 (New Position) | View |
| 2021-02-16 4:30 pm Purchase | 13G | VINCERX PHARMA, INC VINC | CITADEL ADVISORS LLC | 637,931 4.5% | 637,931 (New Position) | View |
| 2021-02-16 4:30 pm Purchase | 13G | Appreciate Holdings Inc. SFRT | CITADEL ADVISORS LLC | 1,172,713 5.1% | 1,172,713 (New Position) | View |
| 2021-02-16 4:30 pm Purchase | 13G | Mudrick Capital Acquisition Corp. II MUDS | CITADEL ADVISORS LLC | 1,480,068 4.7% | 1,480,068 (New Position) | View |
| 2021-02-16 4:30 pm Sale | 13G | Teligent Inc. TLGT | CITADEL ADVISORS LLC | 35,583 0.2% | -167,438 (-82.47%) | View |
| 2021-02-16 4:30 pm Purchase | 13G | 10X Capital Venture Acquisition Corp VCVC | CITADEL ADVISORS LLC | 1,350,018 6.7% | 1,350,018 (New Position) | View |
| 2021-02-16 4:30 pm Purchase | 13G | FOXO TECHNOLOGIES INC FOXO | CITADEL ADVISORS LLC | 1,469,268 7.1% | 1,469,268 (New Position) | View |
| 2021-02-16 4:30 pm Purchase | 13G | ONCORUS INC ONCR | CITADEL ADVISORS LLC | 1,879,337 8.3% | 26,688 (+1.44%) | View |
| 2021-02-16 4:30 pm Sale | 13G | TREPONT ACQUISITION CORP I CL TACA | CITADEL ADVISORS LLC | 1,231,344 5.4% | -8,123 (-0.66%) | View |
| 2021-02-16 4:30 pm Purchase | 13G | PINE IS ACQUISITION CORP PIPP | CITADEL ADVISORS LLC | 1,498,177 6.9% | 1,498,177 (New Position) | View |
| 2021-02-16 4:30 pm Purchase | 13G | Prevail Therapeutics Inc. PRVL | CITADEL ADVISORS LLC | 2,421,024 7.1% | 7,143 (+0.30%) | View |